COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 2148: Articles 21471-21480  | Next

Comparison of the in vitro-efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
Steinhauer, K., Meister, T. L., Todt, D., Krawczyk, A., Passvogel, L., Becker, B., Paulmann, D., Bischoff, B., Pfaender, S., Brill, F., Steinmann, E.
10.1101/2020.10.25.354571 — Posted: 2020-10-26
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
Rosenfeld, R., Noy-Porat, T., Mechaly, A., Makdasi, E., Levy, Y., Alcalay, R., Falach, R., Aftalion, M., Epstein, E., Gur, D., Chitlaru, T., Vitner, E. B., Melamed, S., Politi, B., Zauberman, A., Lazar, S., Evgy, Y., Yitzhaki, S., Shapira, S. C., Israely, T., Mazor, O.
10.1101/2020.10.26.354811 — Posted: 2020-10-26
Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain
Gan, J. L., Huang, R., Warner, G., Kelley, A., McGregor, D., Smider, V. V.
10.1101/2020.10.25.354548 — Posted: 2020-10-26
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Chan, C. E. Z., Seah, S. G. K., Chye, D. H., Massey, S., Torres, M., Lim, A. P. C., Wong, S. K. K., Neo, J. J. Y., Wong, P. S., Lim, J. H., Loh, G. S. L., Wang, D. L., Boyd-Kirkup, J. D., Guan, S., Thakkar, D., Teo, G. H., Purushotorman, K., Hutchinson, P. E., Young, B., Lye, D. C. B., Low, J. G., MacAry, P. A., Hentze, H., Prativadibhayankara, V. S., Ethirajulu, K., O'Connell, D., Comer, J., Tseng, C.-T. K., Barrett, A. D. T., Ingram, P. J., Brasel, T., Hanson, B. J.
10.1101/2020.10.26.355107 — Posted: 2020-10-26
SARS-CoV-2 specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking and large scale production for Adoptive Cell Therapy
Ferreras, C., Pascual-Miguel, B., Mestre-Duran, C., Navarro-Zapata, A., Clares-Villa, L., Martin-Cortazar, C., De Paz, R., Marcos, A., Vicario, J. L., Balas, A., Garcia-Sanchez, F., Eguizabal, C., Solano, C., Mora-Rillo, M., Soria, B., Perez-Martinez, A.
10.1101/2020.10.23.352294 — Posted: 2020-10-26 Discussion: Onsite | Offsite
Tracking cytosine depletion in SARS-CoV-2
Luo, R., Wong, Y.-S., Lam, T.-W.
10.1101/2020.10.26.354787 — Posted: 2020-10-26
The genomic epidemiology of SARS-CoV-2 in Palestine
Qutob, N., Salah, Z., Richard, D., Darwish, H., Sallam, H., Shtayeh, I., Najjar, O., Balloux, F., van Dorp, L.
10.1101/2020.10.26.355677 — Posted: 2020-10-26
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome
Bhatt, P. R., Scaiola, A., Loughran, G., Leibundgut, M., Kratzel, A., McMillan, A. E., O'Connor, K. M., Bode, J. W., Thiel, V., Atkins, J. F., Ban, N.
10.1101/2020.10.26.355099 — Posted: 2020-10-26 Discussion: Offsite
A theoretical analysis of the putative ORF10 protein in SARS-CoV-2
Schuster, N. A.
10.1101/2020.10.26.355784 — Posted: 2020-10-26
Clinical and laboratory characteristics in outpatient diagnosis of COVID-19 in healthcare professionals in Rio de Janeiro, Brazil
Porto, L. C., Costa, C. H., Nunes, A. S., Bouzas, I., Ferreira, T., Porto, V. M., Secco, D. A., COVID-19 PPC group, , Rufino, R.
10.1101/2020.10.22.20217851 — Posted: 2020-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).